Horizon Investments LLC Buys New Position in Privia Health Group, Inc. $PRVA

Horizon Investments LLC bought a new stake in Privia Health Group, Inc. (NASDAQ:PRVA) during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 25,451 shares of the company’s stock, valued at approximately $603,000.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Canada Pension Plan Investment Board raised its position in Privia Health Group by 48.0% in the 2nd quarter. Canada Pension Plan Investment Board now owns 3,700 shares of the company’s stock valued at $85,000 after buying an additional 1,200 shares during the last quarter. GAMMA Investing LLC raised its position in Privia Health Group by 198.5% in the 4th quarter. GAMMA Investing LLC now owns 4,314 shares of the company’s stock valued at $102,000 after buying an additional 2,869 shares during the last quarter. Raymond James Financial Inc. acquired a new stake in Privia Health Group in the 2nd quarter valued at approximately $113,000. Covestor Ltd raised its position in Privia Health Group by 39.8% in the 3rd quarter. Covestor Ltd now owns 5,824 shares of the company’s stock valued at $145,000 after buying an additional 1,657 shares during the last quarter. Finally, CWM LLC raised its position in Privia Health Group by 94.2% in the 3rd quarter. CWM LLC now owns 6,634 shares of the company’s stock valued at $165,000 after buying an additional 3,218 shares during the last quarter. Institutional investors and hedge funds own 94.48% of the company’s stock.

Privia Health Group Trading Down 3.7%

Shares of NASDAQ PRVA opened at $23.10 on Friday. Privia Health Group, Inc. has a 12 month low of $18.77 and a 12 month high of $26.51. The stock has a 50 day moving average of $22.73 and a 200-day moving average of $23.34. The company has a market capitalization of $2.90 billion, a P/E ratio of 144.35, a P/E/G ratio of 1.50 and a beta of 0.96.

Privia Health Group (NASDAQ:PRVA) last issued its earnings results on Thursday, May 7th. The company reported $0.19 EPS for the quarter, topping the consensus estimate of $0.08 by $0.11. Privia Health Group had a return on equity of 2.81% and a net margin of 0.97%.The company had revenue of $603.85 million during the quarter, compared to the consensus estimate of $560.99 million. During the same period in the previous year, the company posted $0.22 EPS. The firm’s revenue for the quarter was up 25.8% compared to the same quarter last year. Analysts predict that Privia Health Group, Inc. will post 0.37 EPS for the current fiscal year.

Insider Transactions at Privia Health Group

In other news, CEO Parth Mehrotra sold 41,999 shares of Privia Health Group stock in a transaction that occurred on Monday, March 9th. The stock was sold at an average price of $22.86, for a total transaction of $960,097.14. Following the completion of the transaction, the chief executive officer directly owned 343,795 shares in the company, valued at approximately $7,859,153.70. The trade was a 10.89% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Matthew Shawn Morris sold 17,096 shares of Privia Health Group stock in a transaction that occurred on Friday, May 1st. The stock was sold at an average price of $24.99, for a total value of $427,229.04. Following the transaction, the director owned 68,188 shares of the company’s stock, valued at $1,704,018.12. This represents a 20.05% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders sold 274,255 shares of company stock worth $6,299,092. 5.70% of the stock is owned by company insiders.

Privia Health Group News Summary

Here are the key news stories impacting Privia Health Group this week:

• Positive Sentiment: Privia Health reported first-quarter results that beat revenue expectations, with sales of $603.85 million versus the $560.99 million estimate, and EPS of $0.19 versus $0.08 expected. The company also said revenue rose 25.8% year over year, and it reiterated full-year 2026 guidance. Article Title
• Positive Sentiment: The company’s updated 2026 outlook calls for revenue of $2.4 billion to $2.5 billion, which is in line with or slightly above market expectations and supports the case for continued growth. Article Title
• Neutral Sentiment: Investors are also parsing the Q1 2026 earnings call transcript and related earnings coverage for management commentary on margins, utilization trends, and the path to hitting full-year targets. Article Title
• Negative Sentiment: Two insider-selling reports may be weighing on sentiment: the CFO sold about $179,690 of stock and a director sold about $427,229 of stock, which can signal caution even when fundamentals are improving. Article Title Article Title

Analysts Set New Price Targets

PRVA has been the subject of a number of analyst reports. Evercore set a $26.00 price target on Privia Health Group in a research note on Wednesday, April 8th. Truist Financial raised their price target on Privia Health Group from $31.00 to $33.00 and gave the company a “buy” rating in a research note on Monday, March 2nd. Jefferies Financial Group restated a “buy” rating and issued a $32.00 price target on shares of Privia Health Group in a research note on Thursday, February 26th. Canaccord Genuity Group decreased their price target on Privia Health Group from $35.00 to $34.00 and set a “buy” rating for the company in a research note on Friday. Finally, Citigroup decreased their price target on Privia Health Group from $34.00 to $32.00 and set a “buy” rating for the company in a research note on Tuesday, March 3rd. Eleven equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $31.23.

About Privia Health Group

Privia Health Group (NASDAQ: PRVA) is a physician enablement company that partners with independent physicians, medical groups and health systems to transform the delivery of patient care. Through a clinically integrated network and a proprietary technology platform, the company supports providers in managing population health, delivering coordinated care and optimizing financial performance under both fee-for-service and value-based reimbursement models.

Founded in 2016 and headquartered in McLean, Virginia, Privia Health has rapidly expanded its footprint to serve multiple metropolitan markets across the United States.